IDEAYA Biosciences (IDYA) Net Equity Issued and Repurchased (2018 - 2026)
IDEAYA Biosciences' Net Equity Issued and Repurchased was $296.88 million in Q3 2026, compared with $384,000 a year earlier and up 796.9% from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, IDEAYA Biosciences' Net Equity Issued and Repurchased was $333.35 million through Sep 30, 2026, up 18.9% year-over-year; for FY2025, it came in at $4.92 million, down 98.3% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -47.4% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $297.67 million in FY2024 (-10.9%), $334.12 million in FY2023 (+278.4%), $88.31 million in FY2022 (+0.1%) and $88.19 million in FY2021 (-27.8%).
- The Q3 2026 figure marks the highest quarterly Net Equity Issued and Repurchased in data going back to Q3 2018.
- Compared with a year earlier, Net Equity Issued and Repurchased was higher in two of the last six quarters, with an average decline of 38.4%.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q3 2024 (growth of 637.3%); the worst was Q4 2025 (a decline of 99.2%).
- Per Business Quant data, IDYA's Net Equity Issued and Repurchased in the three quarters before Q3 2026 was $33.1 million (Q2 2026), $1.19 million (Q1 2026) and $2.18 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | IDEAYA Biosciences | 3.07 Bn | 90.55 Mn | - | 296.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 296.88 Mn |
| Jun 30, 2026 | 33.10 Mn |
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | 2.18 Mn |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.13 Mn |
| Dec 31, 2024 | 277.51 Mn |
| Sep 30, 2024 | 11.84 Mn |
| Jun 30, 2024 | 2.86 Mn |
| Mar 31, 2024 | 5.46 Mn |
| Dec 31, 2023 | 141.05 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 188.54 Mn |
| Mar 31, 2023 | 2.93 Mn |
| Dec 31, 2022 | 462,000.00 |
| Sep 30, 2022 | 86.63 Mn |
| Jun 30, 2022 | 557,000.00 |
| Mar 31, 2022 | 662,000.00 |
| Dec 31, 2021 | 711,000.00 |
API Access
IDEAYA Biosciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();